PRIMAQUINE PHOSPHATE (primaquine phosphate) by Sanofi is clinical pharmacology microbiology mechanism of action primaquine phosphate is an 8-aminoquinoline antimalarial drug. First approved in 2014.
Drug data last refreshed 1w ago
CLINICAL PHARMACOLOGY Microbiology Mechanism of Action Primaquine phosphate is an 8-aminoquinoline antimalarial drug. The mechanism of action has not been fully established. The major assumptions are an inhibition of the mitochondrial system of dormant parasites, and an oxidative stress generated…
Worked on PRIMAQUINE PHOSPHATE at Sanofi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.